美股市场个股详情
CPRX Catalyst Pharmaceuticals
- 21.960
- +0.210+0.97%
收盘价 11/05 16:00 (美东)
- 21.960
- 0.0000.00%
盘后 20:02 (美东)
26.06亿总市值39.21市盈率TTM
22.050最高价21.410最低价87.26万股成交量21.570今开21.750昨收1908.09万成交额0.85%换手率34.86市盈率(静)1.19亿总股本22.27052周最高4.28市净率22.49亿流通值12.43052周最低--股息TTM1.02亿流通股22.270历史最高--股息率TTM2.94%振幅0.370历史最低21.866平均价1股每手
关于Catalyst Pharmaceuticals公司
Catalyst Pharmaceuticals Inc是一家生物制药公司。该公司专注于为患有罕见、衰弱、慢性神经肌肉疾病和神经系统疾病的人开发创新疗法并将其商业化。该公司供应Firdapse，一种专利形式的磷酸阿米吡啶片，用于治疗Lambbert-eaton肌无力综合症患者。
公司介绍
公司代码CPRX
公司名称Catalyst Pharmaceuticals
上市日期2006/11/08
发行价格6.00
成立日期2002
CEOMr. Richard J. Daly
所属市场纳斯达克
员工数量167
年结日12-31
公司地址355 Alhambra Circle,Suite 801
城市Coral Gables
省份佛罗里达州
国家美国
邮编33134
电话1-305-420-3200
董事高管
- 姓名
- 职务
- 年薪
- Richard J. Daly
- Director, President and Chief Executive Officer
- 1407.69万
- Jeffrey Del Carmen
- Executive Vice President and Chief Commercial Officer
- 250.61万
- Dr. Preethi Sundaram, PhD
- Chief Strategy Officer
- --
- Dr. Gary Ingenito,M.D.,PhD
- Chief Medical and Regulatory Officer
- 237.14万
- Brian Elsbernd, J.D.
- Chief Compliance Officer and Chief Legal Officer
- --
- Dr. Steven R. Miller,PhD
- Executive Vice President, Chief Operating Officer and Chief Scientific Officer
- 340.47万
- Michael W. Kalb
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Patrick J. McEnany
- Non-Executive Chairman of the Board
- 214.65万
- Molly Harper
- Independent Director
- 36.31万
- Tamar Thompson
- Independent Director
- 61.04万
- Donald A. Denkhaus
- Independent Director
- 37.62万
- Charles B. O'Keeffe
- Lead Independent Director
- 39.72万
- Dr. David S. Tierney,M.D.
- Independent Director
- 37.10万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据